Categories AlphaGraphs, Earnings, Health Care
PFE Earnings: Key quarterly highlights from Pfizer’s Q4 2023 financial results
Pfizer Inc. (NYSE: PFE) reported fourth quarter 2023 earnings results today.
Revenues declined 41% year-over-year to $14.2 billion, missing estimates.
The company reported a net loss of $3.37 billion, or $0.60 per share, compared to a net income of $4.9 billion, or $0.87 per share, last year. Adjusted EPS decreased 91% to $0.10 but beat expectations.
Pfizer expects revenues of $58.5-61.5 billion for the full year of 2024. Adjusted EPS is expected to be $2.05-2.25.
The stock stayed in green during premarket hours on Tuesday.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
CVX Earnings: Chevron reports lower revenue and profit for Q1 2024
Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or
ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was
